Clinical research

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial

EuroIntervention 2013;8:1134-1142. DOI: 10.4244/EIJV8I10A176

Patrick Tobbia
Patrick Tobbia1, MD; Bruce R. Brodie1*, MD; Bernhard Witzenbichler2, MD; Chris Metzger3, MD; Giulio Guagliumi4, MD; Jennifer Yu5, MD; Mirle A. Kellett6, MD; Thomas Stuckey1, MD; Martin Fahy7, MSc; Roxana Mehran5,7, MD; Gregg W. Stone7,8, MD
1. LeBauer Cardiovascular Research Foundation and Moses Cone Hospital, Greensboro, NC, USA; 2. Charité Campus Benjamin Franklin, Berlin, Germany; 3. Wellmont CVA Heart Institute, Kingsport, TN, USA; 4. Ospedali Riuniti di Bergamo, Berga

Aims: To examine outcomes in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary interve

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bivalirudingeographical variationsprimary pcistemi
Read next article
An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomy

Latest news